described the case of a 61-year-old man affected by MTC who was enrolled on a clinical trial with heat-killed yeast-CEA vaccine, and thereafter on a phase I trial of a PD-L1 inhibitor (avelumab) (215). Here, CD274 is linked to medullary thyroid gland carcinoma.